glp 1 agonist liraglutide Des-Gly4)-Liraglutide Efficacy of the Glucagon-Like Peptide-1
Description
A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D

Diet plays a major role

Scheen, A

Taher J, Baker CL, Cuizon C, Masoudpour H, Zhang R, Farr S, et al
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 566.Mussig K., Staiger H., Machicao F., Haring H.U., Fritsche A
"Orforglipron could help health care providers expand treatment options for patients who prefer oral therapies without compromising clinical results," Dr
